MARKET PULSE-Alnylam, Beam, NII Holdings, Rosetta Genomics, BlackBerry

Mon Jan 13, 2014 10:16am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter, U.S. stock indexes were little changed on Monday. The Dow Jones industrial average was unchanged at 16,437.5, the S&P 500 was down 0.01 percent at 1,842.18 and the Nasdaq Composite was up 0.04 percent at 4176.15.

** ALNYLAM PHARMACEUTICALS INC, $107.66, +62.60 pct

French drugmaker Sanofi will buy a 12 percent stake in Alnylam Pharmaceuticals for $700 million and deepen their partnership to develop drugs for rare genetic diseases.

** BEAM INC, $83.1, +24.09 pct

Suntory Holdings Ltd said it plans to buy Beam for $16 billion, including debt, making the Japanese company the world's third-largest maker of distilled drinks. Beam's brands include Jim Beam, Maker's Mark, Sauza, Canadian Club and Courvoisier.


The Israeli company, which manufactures soda makers, estimated full-year revenue below analyst's expectations, hurt by a challenging holiday season selling in the United States. The company said it expected 2013 revenue of about $562.0 million, compared with analysts' estimates of $563.8 million.   Continued...